EFFICACY AND SAFETY OF A NEW COMBINED MEDICATION WITH RECOMBINANT INTERFERON AND BETAMETHASONE IN THE TREATMENT OF HAY FEVER DURING PERIODS OF EXACERBATION

EFFICACY AND SAFETY OF A NEW COMBINED MEDICATION WITH RECOMBINANT INTERFERON AND BETAMETHASONE IN THE TREATMENT OF HAY FEVER DURING PERIODS OF EXACERBATION

Objective: to assess the efficacy, safety and tolerability of the new combined medication Allergoferon® beta in patients with moderate-to-severe hay fever (seasonal allergic rhinitis and conjunctivitis) during periods of exacerbation. patients and methods: the object of our study was medication Alle...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	A. A. Ryabtseva, N. Y. Sotnikova, O. V. Chumikov, N. A. Stupakova
Format:	Artikel
Sprache:	Russian
Veröffentlicht:	Ophthalmology Publishing Group 2016-09-01
Schriftenreihe:	Oftalʹmologiâ
Schlagworte:	hay fever efficacy safety recombinant interferon betamethasone allergoferon® beta
Online Zugang:	https://www.ophthalmojournal.com/opht/article/view/324

Ähnliche Einträge

Complex treatment of allergic eye diseases using interferon alfa-2b and loratadine gel for topical and external use
von: A. V. Surov,, et al.
Veröffentlicht: (2014-07-01)

Acetaminophen Intake and Risk of Asthma, Hay Fever and Eczema in Early Adolescence
von: Emilija Vlaski, et al.
Veröffentlicht: (2007-09-01)

Microstructure of Temporomandibular Joint Cartilage after Intra-Articular Betamethasone Sodium Phosphate/Betamethasone Dipropionate Injection during the Early Stage of Experimental Osteoarthrosis
von: Irina N. Kostina, et al.
Veröffentlicht: (2014-06-01)

Health service use among children with and without eczema, asthma, and hay fever
von: Hammer-Helmich L, et al.
Veröffentlicht: (2016-09-01)

Betamethasone Treatment Of Ataxia-Telangiectasia
von: J Gordon Millichap
Veröffentlicht: (2007-05-01)

COMPARISON OF EFFICACY OF TOPICAL CALCIPOTRIENE PLUS BETAMETHASONE WITH CALCIPOTRIENE ALONE IN LOCALIZED VITILIGO
von: Usman Riaz, et al.
Veröffentlicht: (2019-04-01)

Comparative study of safety and efficacy of oral betamethasone pulse therapy and azathioprine in vitiligo
von: Mahajabeen Madarkar, et al.
Veröffentlicht: (2019-01-01)

Comparison of the therapeutic effects of medication therapy, specific immunotherapy and anti-IgE (Omalizumab) in patients with hay fever
von: Rui Tang, et al.
Veröffentlicht: (2024-02-01)

Odor-related Chronic Somatic Symptoms Are Associated with Self-Reported Asthma and Hay Fever: The Hordaland Health Study
von: Hilde Gundersen, et al.
Veröffentlicht: (2015-02-01)

Formulation and evaluation of levofloxacin and betamethasone ophthalmic emulgel
von: Hiba Sabah Sabry, et al.
Veröffentlicht: (2021-01-01)

Betamethasone administration as a treatment of choice in local post-tattoo complications
von: O. N. Karymov, et al.
Veröffentlicht: (2020-05-01)

Decreased Risk in the Pancreatic Cancer With History of Hay Fever: A Meta-Analysis
von: Guannan Wang, et al.
Veröffentlicht: (2020-10-01)

Antiangiogenic effect of betamethasone on the chick cam stimulated by TA3 tumor supernatant
von: DAVID LEMUS, et al.
Veröffentlicht: (2001-01-01)

Change in the organ of vision in somatic diseases
von: D I Trukhan, et al.
Veröffentlicht: (2015-08-01)

Effects of compound betamethasone on vocal fold wound healing in rabbit model: A preliminary study
von: Pengcheng Yu, et al.
Veröffentlicht: (2023-04-01)

Effect of betamethasone on the pulp after topical application to the dentin of rat teeth: vascular aspects of the inflammation
von: Elaine Vianna Freitas Fachin, et al.
Veröffentlicht: (2009-08-01)

Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature
von: Pinter A, et al.
Veröffentlicht: (2018-10-01)

A Comparison of Betamethasone Valerate 0.1% Cream Twice Daily Plus Oral Simvastatin Versus Betamethasone Valerate 0.1% Cream Alone in the Treatment of Vitiligo Patients
von: Fariba Iraji, et al.
Veröffentlicht: (2017-01-01)

Insights Into Type I and III Interferons in Asthma and Exacerbations
von: Helen E. Rich, et al.
Veröffentlicht: (2020-09-01)

Effect of Topical Betamethasone Valerate on Inflammation After Cryotherapy in Treatment of Skin Warts
von: Armaghan Kazeminejad, et al.
Veröffentlicht: (2023-08-01)

Effects of single course and multicourse betamethasone prior to birth in the prognosis of the preterm neonates: A randomized, double-blind placebo-control clinical trial study
von: Zoleykha Atarod, et al.
Veröffentlicht: (2014-01-01)

Betamethasone inhibits tumor development, microvessel density and prolongs survival in mice with a multiresistant adenocarcinoma TA3
von: Osvaldo Garrido, et al.
Veröffentlicht: (2010-01-01)

Persistent hiccups following cervical epidural steroid injection with betamethasone
von: Ritz ML, et al.
Veröffentlicht: (2018-10-01)

Multi-Omics Analysis Provides Insight into the Possible Molecular Mechanism of Hay Fever Based on Gut Microbiota
von: Pei Han, et al.
Veröffentlicht: (2022-08-01)

Self-reported hay fever diagnosis and associations with sociodemographic characteristics among adults and children in the United States
von: Jenna Zamil, et al.
Veröffentlicht: (2022-04-01)

Identifying Shared Risk Genes for Asthma, Hay Fever, and Eczema by Multi-Trait and Multiomic Association Analyses
von: Hongping Guo, et al.
Veröffentlicht: (2020-04-01)

Effect of betamethasone on neonatal respiratory failure in late preterm pregnancies
von: Haji Seid Javadi E, et al.
Veröffentlicht: (2015-12-01)

The Effect of Topical Application of 0.1% Betamethasone Ointment on the Peritoneal Adhesion and Inflammation Following Laparotomy: A Histopathological Animal Experiment
von: Seyed Abdollah Mousavi, et al.
Veröffentlicht: (2019-09-01)

Individual characteristics and associated factors of hay fever: A large-scale mHealth study using AllerSearch
von: Takenori Inomata, et al.
Veröffentlicht: (2022-07-01)

Effect of Betamethasone on Acute Phase Reactant Serum Markers in Pregnant Women at Risk of Preterm Labor
von: M Javadian Kootenaee, et al.
Veröffentlicht: (2010-06-01)

Calcipotriol/betamethasone foam for proactive management of plaque psoriasis: four case reports
von: Zoe Apalla, et al.
Veröffentlicht: (2022-07-01)

Effects of betamethasone, sulindac and quinacrine drugs on the inflammatory neoangiogenesis response induced by polyurethane sponge implanted in mouse
von: JULIO ILLANES, et al.
Veröffentlicht: (2002-01-01)

The effects of betamethasone on clinical outcome of the late preterm neonates born between 34 and 36 weeks of gestation
von: Yas Arimi, et al.
Veröffentlicht: (2021-11-01)

New Calcipotriol/Betamethasone Dipropionate Foam Formulation for the Treatment of Psoriasis: An Overview
von: Tiago Torres, et al.
Veröffentlicht: (2018-04-01)

Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis
von: Anderko M, et al.
Veröffentlicht: (2019-09-01)

Individual multidisciplinary clinical phenotypes of nasal and ocular symptoms in hay fever: Crowdsourced cross-sectional study using AllerSearch
von: Takenori Inomata, et al.
Veröffentlicht: (2023-07-01)

Effect of Betamethason on Maternal Hemodynamic Changes in Preterm Labor
von: M Javadian Kutenaie,, et al.
Veröffentlicht: (2009-10-01)

Severe migraine-like headache as unique symptom of steroid withdrawal syndrome betamethasone-induced in lumbar disc herniation
von: Domenico Chirchiglia, et al.
Veröffentlicht: (2019-06-01)

Inhibition of African Swine Fever Virus Replication by Porcine Type I and Type II Interferons
von: Wenhui Fan, et al.
Veröffentlicht: (2020-06-01)

Cubosomal Betamethasone-Salicylic Acid Nano Drug Delivery System for Enhanced Management of Scalp Psoriasis
von: Shalaby RA, et al.
Veröffentlicht: (2022-04-01)